ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antisense Oligonucleotides (ASO) Drug Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-12I12900
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antisense Oligonucleotides ASO Drug Market Research Report 2022
BUY CHAPTERS

Global Antisense Oligonucleotides (ASO) Drug Market Research Report 2024

Code: QYRE-Auto-12I12900
Report
April 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ionis
Novartis
Biogen
Akcea
Therapeutics
Sarepta Therapeutics
ProQR
Exicure Inc
Astrazeneca plc
Dicerna
Silence
Arrowhead
Alnylam
WAVElife
Secarna
The WhiteOak Group, Inc.

Antisense Oligonucleotides (ASO) Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antisense Oligonucleotides (ASO) Drug Market

Antisense Oligonucleotides (ASO) Drug Market

Antisense oligonucleotide (ASO) drugs are small, synthetic single-stranded nucleic acid polymers that can be used to regulate gene expression through a variety of mechanisms.
The global Antisense Oligonucleotides (ASO) Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotides (ASO) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotides (ASO) Drug.

Report Scope

The Antisense Oligonucleotides (ASO) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antisense Oligonucleotides (ASO) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Oligonucleotides (ASO) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antisense Oligonucleotides (ASO) Drug Market Report

Report Metric Details
Report Name Antisense Oligonucleotides (ASO) Drug Market
CAGR 5%
Segment by Type
  • Fomivirsen
  • Spinraza
  • Tegsedi
  • Waylivra
  • Vyondys 53
Segment by Application
  • Single Gene Rare Disease
  • Protein Deposition Disease
  • Chronic Liver Disease
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ionis, Novartis, Biogen, Akcea, Therapeutics, Sarepta Therapeutics, WAVElife, ProQR, Exicure, Secarna, AstraZeneca, The WhiteOak Group, Inc., Dicerna, Silence, Arrowhead, Alnylam
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antisense Oligonucleotides (ASO) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antisense Oligonucleotides (ASO) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antisense Oligonucleotides (ASO) Drug Market report?

Ans: The main players in the Antisense Oligonucleotides (ASO) Drug Market are Ionis, Novartis, Biogen, Akcea, Therapeutics, Sarepta Therapeutics, WAVElife, ProQR, Exicure, Secarna, AstraZeneca, The WhiteOak Group, Inc., Dicerna, Silence, Arrowhead, Alnylam

What are the Application segmentation covered in the Antisense Oligonucleotides (ASO) Drug Market report?

Ans: The Applications covered in the Antisense Oligonucleotides (ASO) Drug Market report are Single Gene Rare Disease, Protein Deposition Disease, Chronic Liver Disease, Others

What are the Type segmentation covered in the Antisense Oligonucleotides (ASO) Drug Market report?

Ans: The Types covered in the Antisense Oligonucleotides (ASO) Drug Market report are Fomivirsen, Spinraza, Tegsedi, Waylivra, Vyondys 53

1 Antisense Oligonucleotides (ASO) Drug Market Overview
1.1 Product Overview and Scope of Antisense Oligonucleotides (ASO) Drug
1.2 Antisense Oligonucleotides (ASO) Drug Segment by Type
1.2.1 Global Antisense Oligonucleotides (ASO) Drug Market Value Comparison by Type (2024-2030)
1.2.2 Fomivirsen
1.2.3 Spinraza
1.2.4 Tegsedi
1.2.5 Waylivra
1.2.6 Vyondys 53
1.3 Antisense Oligonucleotides (ASO) Drug Segment by Application
1.3.1 Global Antisense Oligonucleotides (ASO) Drug Market Value by Application: (2024-2030)
1.3.2 Single Gene Rare Disease
1.3.3 Protein Deposition Disease
1.3.4 Chronic Liver Disease
1.3.5 Others
1.4 Global Antisense Oligonucleotides (ASO) Drug Market Size Estimates and Forecasts
1.4.1 Global Antisense Oligonucleotides (ASO) Drug Revenue 2019-2030
1.4.2 Global Antisense Oligonucleotides (ASO) Drug Sales 2019-2030
1.4.3 Global Antisense Oligonucleotides (ASO) Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antisense Oligonucleotides (ASO) Drug Market Competition by Manufacturers
2.1 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antisense Oligonucleotides (ASO) Drug Average Price by Manufacturers (2019-2024)
2.4 Global Antisense Oligonucleotides (ASO) Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Product Type & Application
2.7 Antisense Oligonucleotides (ASO) Drug Market Competitive Situation and Trends
2.7.1 Antisense Oligonucleotides (ASO) Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antisense Oligonucleotides (ASO) Drug Players Market Share by Revenue
2.7.3 Global Antisense Oligonucleotides (ASO) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antisense Oligonucleotides (ASO) Drug Retrospective Market Scenario by Region
3.1 Global Antisense Oligonucleotides (ASO) Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antisense Oligonucleotides (ASO) Drug Global Antisense Oligonucleotides (ASO) Drug Sales by Region: 2019-2030
3.2.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Region: 2019-2024
3.2.2 Global Antisense Oligonucleotides (ASO) Drug Sales by Region: 2025-2030
3.3 Global Antisense Oligonucleotides (ASO) Drug Global Antisense Oligonucleotides (ASO) Drug Revenue by Region: 2019-2030
3.3.1 Global Antisense Oligonucleotides (ASO) Drug Revenue by Region: 2019-2024
3.3.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Region: 2025-2030
3.4 North America Antisense Oligonucleotides (ASO) Drug Market Facts & Figures by Country
3.4.1 North America Antisense Oligonucleotides (ASO) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2030)
3.4.3 North America Antisense Oligonucleotides (ASO) Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antisense Oligonucleotides (ASO) Drug Market Facts & Figures by Country
3.5.1 Europe Antisense Oligonucleotides (ASO) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2030)
3.5.3 Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antisense Oligonucleotides (ASO) Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Antisense Oligonucleotides (ASO) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Antisense Oligonucleotides (ASO) Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antisense Oligonucleotides (ASO) Drug Market Facts & Figures by Country
3.7.1 Latin America Antisense Oligonucleotides (ASO) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2030)
3.7.3 Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antisense Oligonucleotides (ASO) Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Antisense Oligonucleotides (ASO) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antisense Oligonucleotides (ASO) Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Type (2019-2030)
4.1.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Type (2019-2024)
4.1.2 Global Antisense Oligonucleotides (ASO) Drug Sales by Type (2025-2030)
4.1.3 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2019-2030)
4.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Type (2019-2030)
4.2.1 Global Antisense Oligonucleotides (ASO) Drug Revenue by Type (2019-2024)
4.2.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Type (2025-2030)
4.2.3 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2019-2030)
4.3 Global Antisense Oligonucleotides (ASO) Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2019-2030)
5.1.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2019-2024)
5.1.2 Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2025-2030)
5.1.3 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2019-2030)
5.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Application (2019-2030)
5.2.1 Global Antisense Oligonucleotides (ASO) Drug Revenue by Application (2019-2024)
5.2.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Application (2025-2030)
5.2.3 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2019-2030)
5.3 Global Antisense Oligonucleotides (ASO) Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ionis
6.1.1 Ionis Corporation Information
6.1.2 Ionis Description and Business Overview
6.1.3 Ionis Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ionis Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.1.5 Ionis Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Biogen
6.3.1 Biogen Corporation Information
6.3.2 Biogen Description and Business Overview
6.3.3 Biogen Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biogen Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.3.5 Biogen Recent Developments/Updates
6.4 Akcea
6.4.1 Akcea Corporation Information
6.4.2 Akcea Description and Business Overview
6.4.3 Akcea Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Akcea Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.4.5 Akcea Recent Developments/Updates
6.5 Therapeutics
6.5.1 Therapeutics Corporation Information
6.5.2 Therapeutics Description and Business Overview
6.5.3 Therapeutics Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Therapeutics Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.5.5 Therapeutics Recent Developments/Updates
6.6 Sarepta Therapeutics
6.6.1 Sarepta Therapeutics Corporation Information
6.6.2 Sarepta Therapeutics Description and Business Overview
6.6.3 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.6.5 Sarepta Therapeutics Recent Developments/Updates
6.7 WAVElife
6.6.1 WAVElife Corporation Information
6.6.2 WAVElife Description and Business Overview
6.6.3 WAVElife Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 WAVElife Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.7.5 WAVElife Recent Developments/Updates
6.8 ProQR
6.8.1 ProQR Corporation Information
6.8.2 ProQR Description and Business Overview
6.8.3 ProQR Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ProQR Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.8.5 ProQR Recent Developments/Updates
6.9 Exicure
6.9.1 Exicure Corporation Information
6.9.2 Exicure Description and Business Overview
6.9.3 Exicure Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Exicure Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.9.5 Exicure Recent Developments/Updates
6.10 Secarna
6.10.1 Secarna Corporation Information
6.10.2 Secarna Description and Business Overview
6.10.3 Secarna Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Secarna Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.10.5 Secarna Recent Developments/Updates
6.11 AstraZeneca
6.11.1 AstraZeneca Corporation Information
6.11.2 AstraZeneca Antisense Oligonucleotides (ASO) Drug Description and Business Overview
6.11.3 AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.11.5 AstraZeneca Recent Developments/Updates
6.12 The WhiteOak Group, Inc.
6.12.1 The WhiteOak Group, Inc. Corporation Information
6.12.2 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Description and Business Overview
6.12.3 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.12.5 The WhiteOak Group, Inc. Recent Developments/Updates
6.13 Dicerna
6.13.1 Dicerna Corporation Information
6.13.2 Dicerna Antisense Oligonucleotides (ASO) Drug Description and Business Overview
6.13.3 Dicerna Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Dicerna Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.13.5 Dicerna Recent Developments/Updates
6.14 Silence
6.14.1 Silence Corporation Information
6.14.2 Silence Antisense Oligonucleotides (ASO) Drug Description and Business Overview
6.14.3 Silence Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Silence Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.14.5 Silence Recent Developments/Updates
6.15 Arrowhead
6.15.1 Arrowhead Corporation Information
6.15.2 Arrowhead Antisense Oligonucleotides (ASO) Drug Description and Business Overview
6.15.3 Arrowhead Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Arrowhead Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.15.5 Arrowhead Recent Developments/Updates
6.16 Alnylam
6.16.1 Alnylam Corporation Information
6.16.2 Alnylam Antisense Oligonucleotides (ASO) Drug Description and Business Overview
6.16.3 Alnylam Antisense Oligonucleotides (ASO) Drug Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Alnylam Antisense Oligonucleotides (ASO) Drug Product Portfolio
6.16.5 Alnylam Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antisense Oligonucleotides (ASO) Drug Industry Chain Analysis
7.2 Antisense Oligonucleotides (ASO) Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antisense Oligonucleotides (ASO) Drug Production Mode & Process
7.4 Antisense Oligonucleotides (ASO) Drug Sales and Marketing
7.4.1 Antisense Oligonucleotides (ASO) Drug Sales Channels
7.4.2 Antisense Oligonucleotides (ASO) Drug Distributors
7.5 Antisense Oligonucleotides (ASO) Drug Customers
8 Antisense Oligonucleotides (ASO) Drug Market Dynamics
8.1 Antisense Oligonucleotides (ASO) Drug Industry Trends
8.2 Antisense Oligonucleotides (ASO) Drug Market Drivers
8.3 Antisense Oligonucleotides (ASO) Drug Market Challenges
8.4 Antisense Oligonucleotides (ASO) Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Ionis
Novartis
Biogen
Akcea
Therapeutics
Sarepta Therapeutics
ProQR
Exicure Inc
Astrazeneca plc
Dicerna
Silence
Arrowhead
Alnylam
WAVElife
Secarna
The WhiteOak Group, Inc.
List of Tables
    Table 1. Global Antisense Oligonucleotides (ASO) Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Antisense Oligonucleotides (ASO) Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Antisense Oligonucleotides (ASO) Drug Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Antisense Oligonucleotides (ASO) Drug Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Antisense Oligonucleotides (ASO) Drug Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Antisense Oligonucleotides (ASO) Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Antisense Oligonucleotides (ASO) Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Antisense Oligonucleotides (ASO) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides (ASO) Drug as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Antisense Oligonucleotides (ASO) Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Antisense Oligonucleotides (ASO) Drug Sales by Region (2019-2024) & (K Units)
    Table 18. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2019-2024)
    Table 19. Global Antisense Oligonucleotides (ASO) Drug Sales by Region (2025-2030) & (K Units)
    Table 20. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2025-2030)
    Table 21. Global Antisense Oligonucleotides (ASO) Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Region (2019-2024)
    Table 23. Global Antisense Oligonucleotides (ASO) Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Region (2025-2030)
    Table 25. North America Antisense Oligonucleotides (ASO) Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (K Units)
    Table 27. North America Antisense Oligonucleotides (ASO) Drug Sales by Country (2025-2030) & (K Units)
    Table 28. North America Antisense Oligonucleotides (ASO) Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Antisense Oligonucleotides (ASO) Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Antisense Oligonucleotides (ASO) Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Antisense Oligonucleotides (ASO) Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Antisense Oligonucleotides (ASO) Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Antisense Oligonucleotides (ASO) Drug Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Antisense Oligonucleotides (ASO) Drug Sales (K Units) by Type (2019-2024)
    Table 51. Global Antisense Oligonucleotides (ASO) Drug Sales (K Units) by Type (2025-2030)
    Table 52. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2019-2024)
    Table 53. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2025-2030)
    Table 54. Global Antisense Oligonucleotides (ASO) Drug Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Antisense Oligonucleotides (ASO) Drug Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2019-2024)
    Table 57. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2025-2030)
    Table 58. Global Antisense Oligonucleotides (ASO) Drug Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Antisense Oligonucleotides (ASO) Drug Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Antisense Oligonucleotides (ASO) Drug Sales (K Units) by Application (2019-2024)
    Table 61. Global Antisense Oligonucleotides (ASO) Drug Sales (K Units) by Application (2025-2030)
    Table 62. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2019-2024)
    Table 63. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2025-2030)
    Table 64. Global Antisense Oligonucleotides (ASO) Drug Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Antisense Oligonucleotides (ASO) Drug Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2019-2024)
    Table 67. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2025-2030)
    Table 68. Global Antisense Oligonucleotides (ASO) Drug Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Antisense Oligonucleotides (ASO) Drug Price (US$/Unit) by Application (2025-2030)
    Table 70. Ionis Corporation Information
    Table 71. Ionis Description and Business Overview
    Table 72. Ionis Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Ionis Antisense Oligonucleotides (ASO) Drug Product
    Table 74. Ionis Recent Developments/Updates
    Table 75. Novartis Corporation Information
    Table 76. Novartis Description and Business Overview
    Table 77. Novartis Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Novartis Antisense Oligonucleotides (ASO) Drug Product
    Table 79. Novartis Recent Developments/Updates
    Table 80. Biogen Corporation Information
    Table 81. Biogen Description and Business Overview
    Table 82. Biogen Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Biogen Antisense Oligonucleotides (ASO) Drug Product
    Table 84. Biogen Recent Developments/Updates
    Table 85. Akcea Corporation Information
    Table 86. Akcea Description and Business Overview
    Table 87. Akcea Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Akcea Antisense Oligonucleotides (ASO) Drug Product
    Table 89. Akcea Recent Developments/Updates
    Table 90. Therapeutics Corporation Information
    Table 91. Therapeutics Description and Business Overview
    Table 92. Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Therapeutics Antisense Oligonucleotides (ASO) Drug Product
    Table 94. Therapeutics Recent Developments/Updates
    Table 95. Sarepta Therapeutics Corporation Information
    Table 96. Sarepta Therapeutics Description and Business Overview
    Table 97. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product
    Table 99. Sarepta Therapeutics Recent Developments/Updates
    Table 100. WAVElife Corporation Information
    Table 101. WAVElife Description and Business Overview
    Table 102. WAVElife Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. WAVElife Antisense Oligonucleotides (ASO) Drug Product
    Table 104. WAVElife Recent Developments/Updates
    Table 105. ProQR Corporation Information
    Table 106. ProQR Description and Business Overview
    Table 107. ProQR Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. ProQR Antisense Oligonucleotides (ASO) Drug Product
    Table 109. ProQR Recent Developments/Updates
    Table 110. Exicure Corporation Information
    Table 111. Exicure Description and Business Overview
    Table 112. Exicure Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Exicure Antisense Oligonucleotides (ASO) Drug Product
    Table 114. Exicure Recent Developments/Updates
    Table 115. Secarna Corporation Information
    Table 116. Secarna Description and Business Overview
    Table 117. Secarna Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Secarna Antisense Oligonucleotides (ASO) Drug Product
    Table 119. Secarna Recent Developments/Updates
    Table 120. AstraZeneca Corporation Information
    Table 121. AstraZeneca Description and Business Overview
    Table 122. AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. AstraZeneca Antisense Oligonucleotides (ASO) Drug Product
    Table 124. AstraZeneca Recent Developments/Updates
    Table 125. The WhiteOak Group, Inc. Corporation Information
    Table 126. The WhiteOak Group, Inc. Description and Business Overview
    Table 127. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product
    Table 129. The WhiteOak Group, Inc. Recent Developments/Updates
    Table 130. Dicerna Corporation Information
    Table 131. Dicerna Description and Business Overview
    Table 132. Dicerna Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Dicerna Antisense Oligonucleotides (ASO) Drug Product
    Table 134. Dicerna Recent Developments/Updates
    Table 135. Silence Corporation Information
    Table 136. Silence Description and Business Overview
    Table 137. Silence Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Silence Antisense Oligonucleotides (ASO) Drug Product
    Table 139. Silence Recent Developments/Updates
    Table 140. Arrowhead Corporation Information
    Table 141. Arrowhead Description and Business Overview
    Table 142. Arrowhead Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Arrowhead Antisense Oligonucleotides (ASO) Drug Product
    Table 144. Arrowhead Recent Developments/Updates
    Table 145. Alnylam Corporation Information
    Table 146. Alnylam Description and Business Overview
    Table 147. Alnylam Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Alnylam Antisense Oligonucleotides (ASO) Drug Product
    Table 149. Alnylam Recent Developments/Updates
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Antisense Oligonucleotides (ASO) Drug Distributors List
    Table 153. Antisense Oligonucleotides (ASO) Drug Customers List
    Table 154. Antisense Oligonucleotides (ASO) Drug Market Trends
    Table 155. Antisense Oligonucleotides (ASO) Drug Market Drivers
    Table 156. Antisense Oligonucleotides (ASO) Drug Market Challenges
    Table 157. Antisense Oligonucleotides (ASO) Drug Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Antisense Oligonucleotides (ASO) Drug
    Figure 2. Global Antisense Oligonucleotides (ASO) Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Antisense Oligonucleotides (ASO) Drug Market Share by Type in 2023 & 2030
    Figure 4. Fomivirsen Product Picture
    Figure 5. Spinraza Product Picture
    Figure 6. Tegsedi Product Picture
    Figure 7. Waylivra Product Picture
    Figure 8. Vyondys 53 Product Picture
    Figure 9. Global Antisense Oligonucleotides (ASO) Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application in 2023 & 2030
    Figure 11. Single Gene Rare Disease
    Figure 12. Protein Deposition Disease
    Figure 13. Chronic Liver Disease
    Figure 14. Others
    Figure 15. Global Antisense Oligonucleotides (ASO) Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Antisense Oligonucleotides (ASO) Drug Market Size (2019-2030) & (US$ Million)
    Figure 17. Global Antisense Oligonucleotides (ASO) Drug Sales (2019-2030) & (K Units)
    Figure 18. Global Antisense Oligonucleotides (ASO) Drug Average Price (US$/Unit) & (2019-2030)
    Figure 19. Antisense Oligonucleotides (ASO) Drug Report Years Considered
    Figure 20. Antisense Oligonucleotides (ASO) Drug Sales Share by Manufacturers in 2023
    Figure 21. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Manufacturers in 2023
    Figure 22. The Global 5 and 10 Largest Antisense Oligonucleotides (ASO) Drug Players: Market Share by Revenue in 2023
    Figure 23. Antisense Oligonucleotides (ASO) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 24. Global Antisense Oligonucleotides (ASO) Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 25. North America Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country (2019-2030)
    Figure 26. North America Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country (2019-2030)
    Figure 27. United States Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Canada Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Europe Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country (2019-2030)
    Figure 30. Europe Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country (2019-2030)
    Figure 31. Germany Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. France Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. U.K. Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Italy Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Russia Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2019-2030)
    Figure 37. Asia Pacific Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Region (2019-2030)
    Figure 38. China Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Japan Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. South Korea Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. India Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Australia Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Antisense Oligonucleotides (ASO) Drug Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Antisense Oligonucleotides (ASO) Drug by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Antisense Oligonucleotides (ASO) Drug by Type (2019-2030)
    Figure 57. Global Antisense Oligonucleotides (ASO) Drug Price (US$/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Antisense Oligonucleotides (ASO) Drug by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Antisense Oligonucleotides (ASO) Drug by Application (2019-2030)
    Figure 60. Global Antisense Oligonucleotides (ASO) Drug Price (US$/Unit) by Application (2019-2030)
    Figure 61. Antisense Oligonucleotides (ASO) Drug Value Chain
    Figure 62. Antisense Oligonucleotides (ASO) Drug Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024
Antisense Oligonucleotide ASO Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024
Global ASO based Drug Market Research Report 2024
Global Antisense Oligonucleotide Service Market Research Report 2025
Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024
Global Antisense Oligonucleotides ASOs Drugs Market Research Report 2024
Global Antisense Oligonucleotides Market Research Report 2024
Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024
Global Antisense ODN Market Research Report 2024
Global Oligonucleotide Drugs ONs Market Research Report 2025
Global Antisense Therapy Market Research Report 2024
Global Antisense and RNA Interference Therapeutics Market Research Report 2024
Global siRNA Drug Market Research Report 2024
Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024
Global Oligonucleotide Oligo Drugs Market Research Report 2024
Global Nucleic Acid Drugs Market Research Report 2025
Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025
Global Small Nucleic Acid Drug Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions